Thiamin (vitamin B1) biosynthesis and regulation: A rich source of antimicrobial drug targets?

157Citations
Citations of this article
311Readers
Mendeley users who have this article in their library.

Abstract

Drug resistance of pathogens has necessitated the identification of novel targets for antibiotics. Thiamin (vitamin B1) is an essential cofactor for all organisms in its active form thiamin diphosphate (ThDP). Therefore, its metabolic pathways might be one largely untapped source of antibiotics targets. This review describes bacterial thiamin biosynthetic, salvage, and transport pathways. Essential thiamin synthetic enzymes such as Dxs and ThiE are proposed as promising drug targets. The regulation mechanism of thiamin biosynthesis by ThDP riboswitch is also discussed. As drug targets of existing antimicrobial compound pyrithiamin, the ThDP riboswitch might serves as alternative targets for more antibiotics. © Ivyspring International Publisher.

Cite

CITATION STYLE

APA

Du, Q., Wang, H., & Xie, J. (2011). Thiamin (vitamin B1) biosynthesis and regulation: A rich source of antimicrobial drug targets? International Journal of Biological Sciences. Ivyspring International Publisher. https://doi.org/10.7150/ijbs.7.41

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free